البلد: أيرلندا
اللغة: الإنجليزية
المصدر: HPRA (Health Products Regulatory Authority)
GLUCOSAMINE SULFATE
FMC Pharma Ltd
500 Milligram
Film Coated Tablet
2011-07-22
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Arthriaid 500mg Film-Coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 628mg glucosamine sulfate sodium chloride equivalent to 500 mg glucosamine sulfate. Excipients: Each tablet contains 50.6 mg (2.2 mmol) of sodium. Lactose monohydrate 60.0 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet Off-white, oblong-shaped, film-coated tablet 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Arthriaid tablets are indicated for the treatment of osteoarthritis of low to moderate degree. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Administration:_ Arthriaid tablets should be swallowed whole. _Adults and the elderly_: One Arthriaid tablet should be taken 3 times daily. Or Three Arthriaid tablets to be taken once daily. Efficacy of glucosamine has been demonstrated for periods of up to three months, with a residual effect evident for two months after drug withdrawal. The safety and efficacy of the product were also confirmed in pivotal clinical trials for treatment up to three years. Continuous treatment beyond 3 years cannot be recommended as the safety has not been established beyond this period. _Children:_ Safety and efficacy has not been established in children, therefore, Arthriaid tablets should not be used in persons under the age of 18 years. _Impaired renal and/or liver function_ In patients with impaired renal and/or liver function no dose recommendations can be given, since no studies have been performed. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 26/07/2011_ _CRN 2055044_ _page number: 1_ 4.3 CONTRAINDICATIONS Known sensitivity to glucosamine (or any اقرأ الوثيقة كاملة